PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS

被引:0
|
作者
Tomasiewicz, Krzysztof [1 ]
Modrzewska, Romana [1 ]
机构
[1] Med Univ Lublin, Dept Infect Dis, Lublin, Poland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1342
引用
下载
收藏
页码:907A / 907A
页数:1
相关论文
共 50 条
  • [31] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Mosaburo Kainuma
    Norihiro Furusyo
    Eiji Kajiwara
    Kazuhiro Takahashi
    Hideyuki Nomura
    Yuichi Tanabe
    Takeaki Satoh
    Toshihiro Maruyama
    Makoto Nakamuta
    Kazuhiro Kotoh
    Koichi Azuma
    Junya Shimono
    Shinji Shimoda
    Jun Hayashi
    World Journal of Gastroenterology, 2010, 16 (35) : 4400 - 4409
  • [32] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Kogure, Takayuki
    Ueno, Yoshiyuki
    Fukushima, Koji
    Nagasaki, Futoshi
    Kondo, Yasuteru
    Inoue, Jun
    Matsuda, Yasunori
    Kakazu, Eiji
    Yamamoto, Takeshi
    Onodera, Hiroyoshi
    Miyazaki, Yutaka
    Okamoto, Hiromasa
    Akahane, Takehiro
    Kobayashi, Tomoo
    Mano, Yutaka
    Iwasaki, Takao
    Ishii, Motoyasu
    Shimosegawa, Tooru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (47) : 7225 - 7230
  • [33] Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C
    Hu, C. -C.
    Lin, C. -L.
    Kuo, Y. -L.
    Chien, C. -H.
    Chen, S. -W.
    Yen, C. -L.
    Lin, C. -Y.
    Chien, R. -N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 81 - 90
  • [34] Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
    Bruchfeld, A
    Lindahl, K
    Reichard, O
    Carlsson, T
    Schvarcz, R
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (05) : 316 - 321
  • [35] Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
    Kanda, T.
    Yokosuka, O.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2011, 50 (01) : 41 - 48
  • [36] Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C
    Marangon, A. V.
    Moliterno, R. A.
    Sell, A. M.
    de Moraes, C. F. V.
    Grotto, R. M. T.
    Pardini, M. C.
    De Pauli, D. S.
    Visentainer, J. E. L.
    Silva, G. F.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2012, 39 (04) : 296 - 302
  • [37] The therapeutic effect of ribavirin plus pegylated interferon in chronic hepatitis B and C
    Chien, Rong-Nan
    Hu, Ching-Chih
    Sheen, I-Shyan
    Liaw, Yun-Fan
    Yen, Cho-Li
    Chang, Jia-Jang
    HEPATOLOGY, 2006, 44 (04) : 341A - 341A
  • [38] Assessment of efficacy and safety of PEGylated interferon plus ribavirin in elderly patients with chronic hepatitis C
    Wen, Shi-Chi
    Cheng, Lung-Chih
    Hsu, Jui-Hung
    Lai, Hsin-Wen
    Shih, Pei-Chen
    Tsai, Chi-Chang
    Lee, Ching-Chang
    Kuo, Wu-Hsien
    ADVANCES IN DIGESTIVE MEDICINE, 2018, 5 (03) : 84 - 92
  • [39] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Marugán, MT
    Moreno-Otero, R
    Garcia-Buey, L
    Moreno-Monteagudo, JA
    Vitón, M
    Muñoz, C
    Borque, MJ
    Salcedo-Mora, X
    HEPATOLOGY, 2005, 42 (04) : 668A - 668A
  • [40] A randomised trial of pegylated interferon alpha-2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin
    Ciancio, A.
    Picciotto, A.
    Giordanino, C.
    Smedile, A.
    Tabone, M.
    Manca, A.
    Marenco, G.
    Garbagnoli, P.
    Andreoni, M.
    Cariti, G.
    Calleri, G.
    Sartori, M.
    Cusumano, S.
    Grasso, A.
    Basso, M.
    Rizzetto, M.
    Saracco, G.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S148 - S148